Marketresearchnews

Tuesday, 15 June 2021

Cataract Surgery device Market Size, Share, Demand, Financial Overview, Key Developments, Swot Analysis and Forecast to 2027

The globally market for cataract surgery device is growing steadily. Factors that influence the cataract surgery device market are increasing prevalence of cataract surgery, increasing advance technology in cataract surgery device market, increase in the aging population, prevalence of eye disease and many others. Globally the market for cataract surgery device is expected to grow at the rate of about 5.5% from 2016 to 2022.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2115

Market Drivers and Restraints:

The occurrence of cataract is very common in the elderly population. Other causative agents of cataract are trauma and long-time exposure to radiations. The increasing prevalence of cataract among geriatric population all over the world is inducing high demand for efficient surgical devices to perform cataract surgery. The rise in preference for less invasive procedures has created huge opportunities for the manufacturers to introduce high-tech ophthalmic surgical devices, leading to the expansion of the global cataract surgery device market.

The government sector in various countries are focusing on increasing awareness regarding cataract and are undertaking the initiatives to provide low-cost cataract surgeries in underdeveloped regions, which in turn is fueling the growth of the global cataract surgery device market. The rise in adoption of advanced technology in the healthcare sector for improving the diagnostics, surgical and treatment procedures is impacting positively on the expansion of the global cataract surgery device industry.

However, the population in underdeveloped regions is still unaware of the benefits of cataract surgery, which is negatively impacting on the growth of the global cataract surgery device market. The low penetration of advanced technology and poor primary healthcare infrastructure in underdeveloped regions and in some areas of developing regions are likely to create hindrance in the growth of the global cataract surgery device market during the forecast period.

Market Segmentation:

The global cataract surgery devices market has been segmented on the basis of device type and end-users. Based on device type, the global cataract surgery device market is segmented into Intraocular lens (IOL), Ophthalmic Viscoelastic Device (OVD), Phacoemulsification Equipment and Femtosecond Laser Equipment. Among these, the intraocular lens (IOL) segment is anticipated to project significant growth in the global cataract surgery device market during the forecast period. Based on end-users, the global cataract surgery device market is segmented into hospitals, clinics, ophthalmology centers and others.

Regional Analysis:

The global cataract surgery device market is segmented into five major regions such as North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. Owing to the rapid incorporation of advanced technology in the healthcare sector and increased healthcare expenditure, the North America region is projecting to be the largest market in the global cataract surgery device market.

The Europe region is the second largest market in the global cataract surgery device market due to the increasing incidences of individual suffering from cataract. The high geriatric population and increasing awareness among the population regarding the benefits of cataract surgery are leading to the fastest growth of the global cataract surgery device market. The lack of awareness and poor primary healthcare infrastructure in the underdeveloped areas are negatively impacting on the growth of the cataract surgery device market in the Middle East and Africa region.

Competitive Analysis:

The rapid technological advancement is facilitating the manufacturers to introduce upgraded surgical devices in the global cataract surgery devices market, which in turn is strengthening the competition among the players of the global cataract surgery device market.

On 17Th July 2018, Amring Pharmaceutical Inc., a generic pharmaceutical company, has announced the launch of its latest product, Biolon OVD (Ophthalmic Viscosurgical Device), which will be used while performing cataract surgery.

The key players in the global cataract surgery device market that are profiled in the report published by MRFR are Alcon, Inc. (the U.S), Abbott Laboratories (the U.S.), Carl Zeiss Meditech AG (Germany), Essilor International S.A. (France), Opcon Corporation (Japan), Allergan, Inc. (the U.S.), Bausch & Lomb, Inc. (the U.S.), NIDEK Co., Ltd. (Japan), STAAR Surgical Company (the U.S.) and others.

For More Report Details @ https://www.marketresearchfuture.com/reports/cataract-surgery-device-market-2115

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Research report explores the Pharmaceutical Filtration Market for the forecast period, 2020-2027

Filtration in pharmaceutical has been used to purify or separate the component and also to maintain the sterile conditions during the process to prevent contamination. Various methods are being used for filtration depends on the component that need to be filtered. Major factors such as increasing growth of pharmaceutical industry and rapid growth in the generic drug production are the main reasons driving the market growth. On the other hand the huge capital required to set up new production facilities and stringent government regulations to legalize the filtration process are expected to limit market growth to a certain extent. Globally, the market is growing rapidly and it is anticipated to show an exponential growth reaching approximately Billion in 2022.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2432

Segments:
The pharmaceutical filtrations industryt has been segmented on the basis of type of filtrations, product, and their application in pharmaceutical industry. On the basis of type the market has been segmented as air filtration, water filtration, chemical filtrations, Grade filtration (liquid and gas), and absorptive filtrations. Similarly on the basis of product, the market has been segmented into membrane filters, media filters, cartridges and capsule filtration and others. On the basis of application in pharmaceutical industry the filtrations market has again segment into air purification, water purification, sterilization, cell separation, media and buffer filtrations and others.

Regional Analysis of Pharmaceutical filtration devices Market:
Considering the global scenario of the market, Americas region is believed to be the largest market for Pharmaceutical filtration techniques and devices. Moreover the European market is also growing continuously and slowly catching up with the American market. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the pharmaceutical filtration devices segment during the forecasted period. Middle East & Africa region are likely to have a limited but steady growth in the market.

Key Players for Pharmaceutical filtrations devices Market:
Some of the key players in this market are: GE Healthcare (U.S.), Pall Corporation (U.S.), Parker Hannifin Corporation (U.S.), Sartorius Stedim Biotech S.A. (France), Merck KGaA (Germany), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), and GEA Group (Germany).

The report for Pharmaceutical Filtrations Devices Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

For More Report Details @ https://www.marketresearchfuture.com/reports/pharmaceutical-filtration-devices-market-2432

About Us:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Cyanoacrylate Adhesives Market – Qualitative Insights by 2027

Market Overview:

Cyanoacrylate adhesives bonds numerous plastic materials like polycarbonate, styrene, acrylic, and acrylonitrile butadiene styrene (ABS) as well as metal and ceramic. It can bond to the surface where there is moisture and applied based on cure time, environmental resistance, and requirement of specific substrates. Cyanoacrylate adhesives has short shelf life and should be purchased when required as they are strong and act fast on surface. It has poor moisture and heat resistance however manufacturers are focusing on the development of better shear strength and high toughness cyanoacrylate adhesives to improve impact resistance bond. Increasing demand for plastic, metal, and glass in consumer goods, automotive, and electronics industry is propelling cyanoacrylate adhesives application worldwide.

Get Free Sample Now@ https://www.marketresearchfuture.com/sample_request/7346

Competitive Analysis

3M
Master Bond
Adhesive Systems, Inc.
Permabond LLC.
Tong Shen Enterprise Co., Ltd
Henkel AG & Co.
KGaA
Benson Polymers Limited
Premium Metals & Components Pvt. Ltd.
Royal Adhesives & Sealants, LLC
Cyberbond L.L.C.

Market Segmentation

The global cyanoacrylate adhesive market has been segregated based on type, end-use industry and region. By type, the global cyanoacrylate adhesives market is divided into methyl, ethyl, alkoxy, and others. The methyl segment will grow with a significant CAGR during the forecast period and is expected to witness substantial growth in automotive and electronic industry during the forecast period. Ethyl based Cyanoacrylate Adhesive type is majorly used for bonding plastic or rubber-based substrate thus the segment will witness substantial growth by 2023.

The end-use industries segment of the global cyanoacrylate adhesive market has been divided into automotive, consumer products, healthcare, electronic, and others. In 2017, the automotive segment held the largest share of this market. Cyanoacrylate adhesives has been predominantly used in healthcare segment rather owing to its fast curing properties. Growing use of cyanoacrylate adhesives in the plastic, glass, and metal will accelerate demand in electronic and consumer goods industry.

Regional Analysis

The cyanoacrylate adhesives market has been studied with respect to five regions—Asia-Pacific, North America, Europe, Latin America, and the Middle East & Africa. Asia-pacific is the potential market to the cyanoacrylate adhesives market and is the leading consumer of these adhesives types in terms of volume. The market in Asia-Pacific is expected to grow at a high CAGR owing to the rising product demand in the automotive and healthcare industries. The automotive industry in the region is growing at a phenomenal pace which is projected to fuel market demand for the type in the regional.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/cyanoacrylate-adhesives-market-7346

MEA Urinary Tract Infection (UTI) Drugs Market Growth, Trends and Value Chain 2020-2027

Urinary tract infection (UTI) is the infection of the lower or upper urinary tract generally due to escherichia coli although other bacteria and fundi may be causative organisms. Symptoms include pain with urination, frequent urination and feeling the need to urinate despite having an empty bladder. Risk factors that may cause UTI include female anatomy, sexual intercourse, diabetes, obesityetc. World Health Organization (WHO) estimates that approximately 50 % of women suffer from UTI at some point of time in their lives resulting in more than 1 million hospitalizations per year. WHO estimates the annual cost of UTI infections treatment to be greater than $1 billion. It has further been stated that 1% of boys and 3-8% of girls are diagnosed with UTI. .

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2540

The Middle East and African urinary tract infection (UTI) drugs market is growing due to factors such as catheter associated UTI, hospital borne infections (nosocomial infections), child birth, old age, obesity, growing health awareness especially about women health etc. However, there remain market constraints such as drug resistance, unmet clinical needs, increasing incidence of chronic diseases etc. Another prominent restrain is the excellent efficacy of present antibiotics specially the quinolones. However the rise of drug resistance has negated this constraint and had opened doors to new drug development as a good strategy for UTI treatment.

Taking all these factors into consideration, the Middle East and Africa UTI drugs market had reached around $ 992.84 million from $ 769 million in 2015 by growing at the CAGR of 4.35%.

Study Objectives Middle East and Africa UTI Drugs Market:

To provide detail analysis of the MEA Urinary Tract Infection (UTI) Drugs Market Trends along with forecast for the next 5 years about various segments and sub segments of the Middle East and African UTI Drugs market.
To provide insights about factors affecting the market growth.
To analyze the market based on various analyses which includes price analysis, supply chain analysis, Porters Five Force analysis etc.
To provide past and estimated future revenue of Middle East and Africa UTI drugs market’s segments and sub-segments.
To provide country level analysis of the market with respect to the current market size and future growth prospect.
To provide country level analysis of the market’s segments which includes by drug class, by clinical indication, by end users and other sub segments.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies and drawing a competitive landscape of the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments taking place globally.

Intended Audience

UTI drugs manufacturers
UTI drugs suppliers
Private research laboratories
Research and development (R&D) companies
Market research and consulting service providers
Government research laboratories
Contract manufacturing organizations

Key Players of Middle East and Africa UTI Drugs Market:

Some of the key players in this market are: Bayer AG, Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Cipla Inc., Dr. Reddy’s Laboratories Ltd. and others.

Segments:

Middle East and Africa UTI drugs market has been segmented on the basis of drug class which comprises of quinolones, aminoglycosides, β-lactam, azoles and others. On the basis of clinical indications this market is segmented into urethritis, cystitis, and pyelonephritis. On the basis of end users the market is segmented into hospitals and self-administered.

Regional Analysis of Middle East and Africa UTI Drugs Market:

UAE is the largest market of UTI drugs in Middle East and African UTI drugs market closely followed by Egypt. South Africa ranks high in the agendas of many Indian based pharmaceutical firms. The rest of African market is the fastest growing market of UTI drug since there are huge unmet medical needs.

The report about Middle East and Africa UTI Drugs Market by Market Research Future comprises extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value & volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of different markets segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/mea-uti-drugs-market-2540

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Drug Discovery Informatics Market: Drivers, Restraints, Opportunities, and Threats (2020-2027)

Global drug discovery informatics markett size is expected to register a healthy CAGR over the forecast period. The market held a market value of USD 1,680.6 million in 2017 and is projected to grow at a CAGR of 11.5% during the forecast period. Drug discovery and development is a highly intricate process requiring the generation of very large amounts of data and information. Large amounts of data are generated using a variety of innovative technologies, and the limiting step is accessing, searching and integrating this data. The current approaches to collect information from various sources have been dealt with in some cases where the data types are very least well-defined or largely homogeneous. However, the world is on the verge of a new age of drug discovery informatics, the methods and approaches in which are dealing with gathering information from data and knowledge from information are undergoing a paradigm shift. Mining and integration of domain-specific information such as chemical and genomic data will continue to develop in the near future.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7831

Drug discovery is a functional process in pharmaceutical and biotechnology companies. It involves different steps and procedures that depend on in-silico tools for reducing the complexity of a process. Some of the factors driving the market growth are a rising worldwide focus on drug discovery, growing need to control drug discovery and development costs, growth in R&D expenditure, and increasing burden of chronic diseases. For instance, according to the World Health Organization (WHO), in 2001, chronic diseases contributed around 60% of the 56.5 million total reported deaths across the world and approximately 46% of the global burden of disease, which is projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide. On the other hand, high pricing and setup cost of informatics software is anticipated to restrict the market growth during the forecast period.

Segmentation

The global drug discovery informatics market has been segmented into product, mode, service, end user, and region.

By product, the market has been segmented into discovery informatics and development informatics.

On the basis of mode, the market has been divided into in-house informatics and outsourced informatics.

By service, the market has been classified into sequencing and target data analysis, docking, molecular modeling, clinical trial data management, and others. The sequencing and target data analysis segment is expected to dominate the market over the forecast period due to rising application of informatics solutions in targeted analysis and a large amount of data generated during the drug discovery process.

Based on end user, the market has been categorized into pharmaceutical and biotechnology industries, contract research organizations (CROs), and others.

The global drug discovery informatics market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The drug discovery informatics market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.

The European drug discovery informatics market has been segmented into Western Europe and Eastern Europe. The Western Europe drug discovery informatics market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The drug discovery informatics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The drug discovery informatics market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

Few of the spearheads in the global drug discovery informatics market are Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault Systèmes.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/drug-discovery-informatics-market-7831

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Healthcare Information Systems Market Growth, Trends and Value Chain 2020-2027

The global healthcare information systems market size is expected to register a CAGR of 10.0% during the forecast period of 2018 to 2023.

Healthcare information technology offers solutions for security and data management of information related with healthcare. Currently, information technology has more effect on the cost quality and safety associated with healthcare. Some commonly used applications in the healthcare industry include electronic medical records, healthcare records and personal health records.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7325

Healthcare Information Systems Market Segmentation

The global healthcare information systems market is segmented based on type, components, deployment, end user, and region.

On the basis of type, the market is segmented into hospital information systems, pharmacy information systems, laboratory information systems, medical imaging information system, revenue cycle management. The hospital information systems segment is sub-segmented into electronic health record, electronic medical record, real-time healthcare, patient engagement solutions, population health management and others. The pharmacy information systems segment is sub-segmented into prescription management, automated dispensing systems, inventory management and others. The medical imaging information System is sub-segmented into radiology information systems, monitoring analysis software, picture archiving & communication systems and others. Based on components, the market is divided into two, i.e., Software and Hardware. Based on deployment, the market is divided into web-based, on premise and cloud-based. By end user, the market is divided into hospitals, diagnostics centre, academic and research institution, and others. In the current scope of the study, the above-mentioned segments are covered into four global regions, namely- the Americas, Europe, Asia Pacific and the Middle East & Africa.

Healthcare Information Systems Regional Market Summary

The Americas dominated the global market of healthcare information systems. Rising demand for high quality diagnostics system is the main reason behind the supremacy of the North America’s healthcare information system market. Furthermore, large-scale implementation and storage of electronic records in the healthcare system witnessed in the countries such as Canada and the U.S is supporting the expansion of this regional healthcare information system market.

In 2017, it was estimated that Europe stood second in the global healthcare information systems market. This can be attributed due to the presence of a well-developed healthcare infrastructure, increasing awareness for the condition and presence of developed economies within the region.

Asia Pacific was the fastest growing region for the global healthcare information systems market in 2017. Asia-Pacific has a huge market potential for Healthcare IT industry. India and China are some of the rapidly growing countries, followed by South Korea. Consequently, the government in these rapidly developing economies have taken various efforts to improve healthcare services and provide better infrastructure.

On the other hand, the Middle East and Africa held least share in the global healthcare information systems market. Presence of poor economies and low per capita income, especially within the African region make the market to lag within the region. Most of the market share within this region is estimated to be held by the Middle East due to increasing government funding in the healthcare, and presence of developed economies like UAE, Kuwait, Dubai, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-information-systems-market-7325

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Radiofrequency Ablation Devices Market Size, Share, Demand, Financial Overview, Key Developments, Swot Analysis and Forecast to 2027

The global radiofrequency ablation devices market size is expected to register a CAGR of 11.2% during the forecast period of 2018 to 2023.

Radiofrequency ablation (RFA) uses thermal energy to achieve targeted tissue destruction. Within the GI tract, Radiofrequency ablation was primarily studied for the treatment of dysplastic Barrett’s esophagus (BE), and this continues to be one of the common applications. Indications for Radiofrequency ablation within the GI tract continue to progress. It has been used in the treatment of esophageal squamous cell dysplasia, cholangiocarcinoma, radiation proctopathy, gastric antral vascular ectasia (GAVE), and pancreatic neoplasia, among other conditions.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7634

Radiofrequency ablation devices use an electrosurgical generator connected to bipolar electrode arrays to deliver thermal energy to tissue. Electricity travels through tissue between alternating positive and negative poles along the electrode arrays of the radiofrequency ablation device in the radiofrequency range of 450 to 500 kHz.

Segmentation

The global radiofrequency ablation devices market is segmented on the basis of type, application, and region.

On the basis of the type, the global radiofrequency ablation devices market is segmented into Unipolar radiofrequency ablation and Bipolar radiofrequency ablation. By application, the global radiofrequency ablation devices market is categorized into Surgical Oncology, Cardiology and Cardiac Rhythm Management, Gynecology, Cosmetology, Pain Management

Key players

Some of the key players in the global radiofrequency ablation devices market are Boston scientific corporation, Medtronic Inc, Stryker, Cosman Medical, Inc., St. Jude Medical, Smith & Nephew, Johnson & Johnson (J&J) Services, LLC, Angiodynamics, RF Medical Co, Ltd, AtriCure, Inc., and others

Regional Market

The Americas dominates the global market for radiofrequency ablation devices owing a growing number of lung cancer cases like, Non-Small Cell Lung Cancer (NSCLC) which is the most common type of lung cancer, accounting for 80-85% of all lung cancer cases. It is generally a slow growing and spreading as compared to small cell lung cancer (SCLC). Small cell lung cancer used to account for 12-13% of lung cancers. However, there has been a shift from NSCLC to SCLC in recent years which has propelled the growth of the radiofrequency ablation devices market.

In 2017, it was estimated that Europe stood second in the global radiofrequency ablation devices market.

Asia-Pacific was the fastest growing region for the global radiofrequency ablation devices market in 2017. Factors such as increasing awareness of the cardiac disease, growing healthcare industries, and the development of various treatment methods for gynecology and cosmetology drives the market in this region.

On the other hand, the Middle East and Africa holds the least share in the global radiofrequency ablation devices market. The presence of poor economies and low per capita income, especially within the African region make the market to lag within the region. A majority of the market share within this region is estimated to be held by the Middle East due to increasing government funding in the healthcare for healthcare, and presence of developed economies like UAE, Kuwait, Dubai, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/radiofrequency-ablation-devices-market-7634

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com